Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2018 · 10-Q
Revenue$239.00K$239.00K+113.4% vs Q2 2017 Net Income-$3.22M-$3.22MN/M vs Q2 2017 EPS Diluted-$0.76-$0.76N/M vs Q2 2017 Operating Income-$3,252,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$2,819,000N/M Margins · derivedOperating margin-1360.7%+1289.3 pt vs Q2 2017
Net margin-1346.0%+1283.4 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 9, 2018 · 40 d after period end